Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist

Trial Profile

Assessment Of Follow-Up Methods For Patients Treated In The Long-Term With A Specific Aldosterone Receptor Antagonist

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2012

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Acronyms PERGAME
  • Sponsors Pfizer
  • Most Recent Events

    • 25 May 2012 Actual patient number changed 500 to 160 according to ClinicalTrials.gov.
    • 29 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top